Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Wobser

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Experimental Dermatology|March 18, 2015
Aggressive primary cutaneous B-cell lymphomas show increased Angiopoietin-2-induced angiogenesisMartin Teichert, Christine Stumpf, Nina Booken, et al.
Oncogene|December 2, 2020
Correction: The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expressionChristina Jessen, Julia K C Kreß, Apoorva Baluapuri, et al.
Oncogene|September 26, 2020
The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expressionChristina Jessen, Julia K C Kreß, Apoorva Baluapuri, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 10, 2019
Primary cutaneous diffuse large B-cell lymphoma, NOS and leg type: Clinical, morphologic and prognostic differencesMoritz Felcht, Claus-Detlev Klemke, Jan Peter Nicolay, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 29, 2019
Primär kutanes diffus-großzelliges B-Zell-Lymphom, NOS oder leg type: klinische, morphologische und prognostische UnterschiedeMoritz Felcht, Claus-Detlev Klemke, Jan Peter Nicolay, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 3, 2024
Pegylated interferon-α2a in cutaneous T-cell lymphoma - a multicenter retrospective data analysis with 70 patientsInga Hansen-Abeck, Glenn Geidel, Finn Abeck, et al.
The Journal of Investigative Dermatology|September 4, 2021
Merkel Cell Polyomavirus‒Negative Merkel Cell Carcinoma Originating from In Situ Squamous Cell Carcinoma: A Keratinocytic Tumor with Neuroendocrine DifferentiationThibault Kervarrec, Silke Appenzeller, Mahtab Samimi, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 10, 2018
S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 2: Therapie und Nachsorge (ICD10 C82 - C86)Edgar Dippel, Chalid Assaf, Jürgen C Becker, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 12, 2017
S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 1: Klassifikation und Diagnostik (ICD10 C82 - C86)Edgar Dippel, Chalid Assaf, Jürgen C Becker, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 28, 2017
S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 2: Treatment and Follow-up (ICD10 C82 - C86)Edgar Dippel, Chalid Assaf, Jürgen C Becker, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Experimental Dermatology|March 18, 2015
Aggressive primary cutaneous B-cell lymphomas show increased Angiopoietin-2-induced angiogenesisMartin Teichert, Christine Stumpf, Nina Booken, et al.
Oncogene|December 2, 2020
Correction: The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expressionChristina Jessen, Julia K C Kreß, Apoorva Baluapuri, et al.
Oncogene|September 26, 2020
The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expressionChristina Jessen, Julia K C Kreß, Apoorva Baluapuri, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 10, 2019
Primary cutaneous diffuse large B-cell lymphoma, NOS and leg type: Clinical, morphologic and prognostic differencesMoritz Felcht, Claus-Detlev Klemke, Jan Peter Nicolay, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 29, 2019
Primär kutanes diffus-großzelliges B-Zell-Lymphom, NOS oder leg type: klinische, morphologische und prognostische UnterschiedeMoritz Felcht, Claus-Detlev Klemke, Jan Peter Nicolay, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 3, 2024
Pegylated interferon-α2a in cutaneous T-cell lymphoma - a multicenter retrospective data analysis with 70 patientsInga Hansen-Abeck, Glenn Geidel, Finn Abeck, et al.
The Journal of Investigative Dermatology|September 4, 2021
Merkel Cell Polyomavirus‒Negative Merkel Cell Carcinoma Originating from In Situ Squamous Cell Carcinoma: A Keratinocytic Tumor with Neuroendocrine DifferentiationThibault Kervarrec, Silke Appenzeller, Mahtab Samimi, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 10, 2018
S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 2: Therapie und Nachsorge (ICD10 C82 - C86)Edgar Dippel, Chalid Assaf, Jürgen C Becker, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 12, 2017
S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 1: Klassifikation und Diagnostik (ICD10 C82 - C86)Edgar Dippel, Chalid Assaf, Jürgen C Becker, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 28, 2017
S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 2: Treatment and Follow-up (ICD10 C82 - C86)Edgar Dippel, Chalid Assaf, Jürgen C Becker, et al.
Pageof 11